TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 23 filers reported holding TRINITY BIOTECH PLC in Q4 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,112 | -22.7% | 1,512,975 | 0.0% | 1.76% | +106.2% |
| Q2 2023 | $1,439 | -3.6% | 1,512,975 | -4.7% | 0.85% | +10.2% |
| Q1 2023 | $1,493 | -9.8% | 1,587,975 | -5.1% | 0.78% | -56.6% |
| Q4 2022 | $1,656 | -99.9% | 1,672,648 | -19.1% | 1.79% | -0.6% |
| Q3 2022 | $2,215,000 | -20.4% | 2,068,245 | -8.9% | 1.80% | -2.8% |
| Q2 2022 | $2,782,000 | +15.6% | 2,270,717 | 0.0% | 1.85% | +65.8% |
| Q1 2022 | $2,407,000 | +664.1% | 2,270,717 | +932.4% | 1.12% | +1517.4% |
| Q4 2021 | $315,000 | -70.2% | 219,946 | -55.0% | 0.07% | -86.3% |
| Q3 2021 | $1,056,000 | -26.5% | 488,934 | 0.0% | 0.50% | -28.2% |
| Q2 2021 | $1,437,000 | -21.8% | 488,934 | 0.0% | 0.70% | -19.1% |
| Q1 2021 | $1,838,000 | -51.4% | 488,934 | -50.7% | 0.86% | -24.6% |
| Q4 2020 | $3,782,000 | +37.2% | 992,614 | -27.3% | 1.15% | -22.9% |
| Q3 2020 | $2,756,000 | -47.5% | 1,364,599 | -43.3% | 1.49% | +8.4% |
| Q2 2020 | $5,248,000 | +58.9% | 2,407,235 | -19.8% | 1.37% | +25.5% |
| Q1 2020 | $3,303,000 | +6.4% | 3,002,572 | 0.0% | 1.09% | +3.5% |
| Q4 2019 | $3,103,000 | -10.4% | 3,002,572 | +4.9% | 1.06% | +12.1% |
| Q3 2019 | $3,464,000 | -9.2% | 2,862,880 | +23.9% | 0.94% | -13.8% |
| Q2 2019 | $3,813,000 | -19.3% | 2,310,955 | +39.4% | 1.09% | -23.2% |
| Q1 2019 | $4,723,000 | +25.8% | 1,657,216 | +1.1% | 1.42% | -18.7% |
| Q4 2018 | $3,753,000 | +7.6% | 1,638,846 | +87.9% | 1.75% | +32.4% |
| Q3 2018 | $3,488,000 | -5.6% | 872,047 | +18.0% | 1.32% | -8.6% |
| Q2 2018 | $3,694,000 | -2.9% | 738,829 | 0.0% | 1.45% | -11.5% |
| Q1 2018 | $3,805,000 | +1.0% | 738,829 | 0.0% | 1.63% | +6.4% |
| Q4 2017 | $3,768,000 | -9.1% | 738,829 | 0.0% | 1.54% | -7.0% |
| Q3 2017 | $4,145,000 | -6.5% | 738,829 | 0.0% | 1.65% | -1.5% |
| Q2 2017 | $4,433,000 | +0.7% | 738,829 | 0.0% | 1.68% | -13.1% |
| Q1 2017 | $4,403,000 | -13.9% | 738,829 | 0.0% | 1.93% | -25.5% |
| Q4 2016 | $5,113,000 | – | 738,829 | – | 2.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |